Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (681-690 of 1,253) with videos related to

Pageof 126
Sort By:
American Heart Journal|March 20, 2019
Peripheral blood metabolite profiles associated with new onset atrial fibrillationRalf E Harskamp, Thomas M Granger, Robert M Clare, et al.
Journal of Interventional Cardiology|September 21, 2007
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trialsRajendra H Mehta, Adam B Greenbaum, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|February 4, 2022
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous InterventionRalf E Harskamp, Alexander C Fanaroff, Renato D Lopes, et al.
Circulation|August 1, 1993
Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusionM W Krucoff, M A Croll, J E Pope, et al.
Heart (British Cardiac Society)|May 19, 2009
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?K R Bainey, Y Fu, C B Granger, et al.
Lancet (London, England)|August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importanceColette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Journal of the American Heart Association|May 8, 2020
Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical TherapyMika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, et al.
Circulation|December 6, 2001
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialM A Lauer, P L Houghtaling, J G Peterson, et al.
Circulation|March 1, 1996
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trialC B Granger, J Hirsch, R M Califf, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 24, 2014
Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery diseaseBenjamin A Steinberg, Samuel H Broderick, Renato D Lopes, et al.
Pageof 126

Showing results (681-690 of 1,253) with videos related to

Sort By:
Pageof 126
American Heart Journal|March 20, 2019
Peripheral blood metabolite profiles associated with new onset atrial fibrillationRalf E Harskamp, Thomas M Granger, Robert M Clare, et al.
Journal of Interventional Cardiology|September 21, 2007
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trialsRajendra H Mehta, Adam B Greenbaum, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|February 4, 2022
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous InterventionRalf E Harskamp, Alexander C Fanaroff, Renato D Lopes, et al.
Circulation|August 1, 1993
Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusionM W Krucoff, M A Croll, J E Pope, et al.
Heart (British Cardiac Society)|May 19, 2009
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?K R Bainey, Y Fu, C B Granger, et al.
Lancet (London, England)|August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importanceColette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Journal of the American Heart Association|May 8, 2020
Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical TherapyMika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, et al.
Circulation|December 6, 2001
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialM A Lauer, P L Houghtaling, J G Peterson, et al.
Circulation|March 1, 1996
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trialC B Granger, J Hirsch, R M Califf, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 24, 2014
Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery diseaseBenjamin A Steinberg, Samuel H Broderick, Renato D Lopes, et al.
Pageof 126